|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.00 USD | -0.73% |
|
-9.96% | -30.30% |
| 08/06 | Sarepta Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 10:40 AM | |
| 04/06 | Sarepta Therapeutics, Inc. - Shareholder/Analyst Call |
Main competitors
| Revenues (N-1) | Net Margin (N-1) | EBIT Margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
|---|---|---|---|---|---|---|---|
 | 219.82Cr | -32.45% | -31.83% | -37.9% | -13.83% | -0.04x | |
| 67Cr | -85.44% | -79.49% | -657.14% | -37.89% | 1.47x | |
| Average | 143.56Cr | -58.95% | -55.66% | -347.52% | -25.86% | 0.72x | |
| Weighted average by Cap. | 128.63Cr | -64.13% | -60.33% | -408.13% | -28.22% | 0.86x |
- Stock Market
- Stocks
- SRPT Stock
- Sector Sarepta Therapeutics, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition